Laura Maccari

874 total citations
24 papers, 662 citations indexed

About

Laura Maccari is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Laura Maccari has authored 24 papers receiving a total of 662 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Laura Maccari's work include Receptor Mechanisms and Signaling (7 papers), Microtubule and mitosis dynamics (5 papers) and Cancer Treatment and Pharmacology (5 papers). Laura Maccari is often cited by papers focused on Receptor Mechanisms and Signaling (7 papers), Microtubule and mitosis dynamics (5 papers) and Cancer Treatment and Pharmacology (5 papers). Laura Maccari collaborates with scholars based in Italy, United States and France. Laura Maccari's co-authors include Maurizio Botta, Fabrizio Manetti, Federico Corelli, Giovannella Strappaghetti, Laura Betti, Gino Giannaccini, Stefano Corsano, Roberta Barbaro, Claudia Lamanna and Göran Westerberg and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and European Journal of Medicinal Chemistry.

In The Last Decade

Laura Maccari

24 papers receiving 647 citations

Peers

Countries citing papers authored by Laura Maccari

Since Specialization

Citations

This map shows the geographic impact of Laura Maccari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Maccari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Maccari more than expected).

Fields of papers citing papers by Laura Maccari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Maccari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Maccari. The network helps show where Laura Maccari may publish in the future.

Co-authorship network of co-authors of Laura Maccari

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Maccari. A scholar is included among the top collaborators of Laura Maccari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Maccari. Laura Maccari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	SRC Tyrosine Kinase Inhibitor and X-rays Combined Effect on Glioblastoma Cell Lines 2020 ·International Journal of Molecular Sciences ·Filippo Torrisi, Luigi Minafra, Francesco Paolo Cammarata, (unknown), Marco Calvaruso, Nunzio Vicario, Laura Maccari, Elodie A. Pérès, Uğur Özçelik, Myriam Bernaudin, Lorenzo Botta, G. Russo, Rosalba Parenti, Samuel Valable	23
2	A New Strategy for Glioblastoma Treatment: In Vitro and In Vivo Preclinical Characterization of Si306, a Pyrazolo[3,4-d]Pyrimidine Dual Src/P-Glycoprotein Inhibitor 2019 ·Cancers ·Anna Lucia Fallacara, Claudio Zamperini, Ana Podolski-Renić, Jelena Dinić, Tijana Stanković, (unknown), Arianna Mancini, (unknown), (unknown), (unknown), Francesca Bugli, Maurizio Sanguinetti, Riccardo Torelli, Maurizio Martini, Laura Maccari, Massimo Valoti, Elena Dreassi, Maurizio Botta, Milica Pešić, Silvia Schenone	39
3	In vitro characterization, ADME analysis, and histological and toxicological evaluation of BM1, a macrocyclic amidinourea active against azole-resistant Candida strains 2019 ·International Journal of Antimicrobial Agents ·(unknown), (unknown), (unknown), Ilaria D’Agostino, (unknown), (unknown), Claudio Zamperini, Elena Dreassi, Laura Maccari, Riccardo Torelli, Cécilia Martini, (unknown), Jacques F. Meis, Nitesh Khandelwal, Rajendra Prasad, Maurizio Sanguinetti, Francesca Bugli, Maurizio Botta	17
4	Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line 2019 ·International Journal of Molecular Sciences ·Francesco Paolo Cammarata, Filippo Torrisi, Giusi Irma Forte, Luigi Minafra, Valentina Bravatà, Pietro Pisciotta, (unknown), Marco Calvaruso, Giada Petringa, G.A.P. Cirrone, Anna Lucia Fallacara, Laura Maccari, Maurizio Botta, Silvia Schenone, Rosalba Parenti, G. Cuttone, G. Russo	28
5	Identification of novel nt-MGAM inhibitors for potential treatment of type 2 diabetes: Virtual screening, atom based 3D-QSAR model, docking analysis and ADME study 2017 ·Computational Biology and Chemistry ·(unknown), (unknown), Laura Maccari, (unknown), (unknown), (unknown)	11
6	Novel Hits in the Correction of ΔF508-Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Protein: Synthesis, Pharmacological, and ADME Evaluation of Tetrahydropyrido[4,3-d]pyrimidines for the Potential Treatment of Cystic Fibrosis 2015 ·Journal of Medicinal Chemistry ·(unknown), Laura Bettinetti, (unknown), Luis J. V. Galietta, Salvatore La Rosa, Letizia Magnoni, Nicoletta Pedemonte, (unknown), Laura Maccari	13
7	The Chaperoning Activity of Amino-oxyacetic Acid on Folding-Defective Variants of Human Alanine:Glyoxylate Aminotransferase Causing Primary Hyperoxaluria Type I 2015 ·ACS Chemical Biology ·Elisa Oppici, Riccardo Montioli, Mirco Dindo, Laura Maccari, (unknown), (unknown), (unknown), Carla Borri Voltattorni, Barbara Cellini	21
8	Design and synthesis of a hybrid series of potent and selective agonists of α7 nicotinic acetylcholine receptor 2014 ·European Journal of Medicinal Chemistry ·(unknown), (unknown), Thomas A. Comery, John Dunlop, (unknown), Chiara Ghiron, Simon N. Haydar, Laura Maccari, (unknown), Elisa Turlizzi, Riccardo Zanaletti, Jean Zhang	16
9	A Homogeneous HTRF Assay for the Identification of Inhibitors of the TWEAK-Fn14 Protein Interaction 2012 ·SLAS DISCOVERY ·(unknown), (unknown), (unknown), Hanna Axelsson, Elisa Mori, Simonetta Bernocco, (unknown), (unknown), (unknown), (unknown), Laura Maccari, Natalia Markova, (unknown), (unknown), Johan Schultz, Wolfgang Fecke	10
10	N-[5-(5-Fluoropyridin-3-yl)-1H-pyrazol-3-yl]-4-piperidin-1-ylbutyramide (SEN78702, WYE-308775): A Medicinal Chemistry Effort toward an α7 Nicotinic Acetylcholine Receptor Agonist Preclinical Candidate 2012 ·Journal of Medicinal Chemistry ·Riccardo Zanaletti, Laura Bettinetti, (unknown), Ilaria Ceccarelli, (unknown), Thomas A. Comery, John Dunlop, (unknown), Chiara Ghiron, Simon N. Haydar, Flora Jow, Laura Maccari, (unknown), (unknown), Carmela Pratelli, Carla Scali, Elisa Turlizzi, Michela Valacchi	12
11	Straightforward Recursive Partitioning Model for Discarding Insoluble Compounds in the Drug Discovery Process 2008 ·Journal of Medicinal Chemistry ·Claudia Lamanna, (unknown), Alessandro Padova, Göran Westerberg, Laura Maccari	62
12	A pharmacophore modeling approach to design new taxol® mimics: towards the synthesis of potential anticancer and MDR-reversing agent 2006 ·ARKIVOC ·(unknown), (unknown), (unknown), (unknown), Daniele Castagnolo, Laura Maccari, Stefano Forli, Fabrizio Manetti, Federico Corelli, Maurizio Botta	2
13	Variable selection and specification of robust QSAR models from multicollinear data: arylpiperazinyl derivatives with affinity and selectivity for ?2-adrenoceptors 2004 ·Journal of Computer-Aided Molecular Design ·David W. Salt, Laura Maccari, Maurizio Botta, Martyn G. Ford	10
14	Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine 2004 ·Bioorganic & Medicinal Chemistry Letters ·Oriol Pineda, Jaume Farràs, Laura Maccari, Fabrizio Manetti, Maurizio Botta, Jaume Vilarrasa	54
15	3D QSAR Models of Interactions Between β-Tubulin and Microtubule Stabilizing Antimitotic Agents (MSAA): A Survey on Taxanes and Epothilones 2004 ·Current Topics in Medicinal Chemistry ·Fabrizio Manetti, Laura Maccari, Federico Corelli, Maurizio Botta	27
16	3D QSAR studies for the β-tubulin binding site of microtubule-stabilizing anticancer agents (MSAAs) 2003 ·Il Farmaco ·Laura Maccari, Fabrizio Manetti, Federico Corelli, Maurizio Botta	9
17	3D QSAR studies of the interaction between β-tubulin and microtubule stabilizing antimitotic agents (MSAA). A combined pharmacophore generation and pseudoreceptor modeling approach applied to taxanes and epothilones 2003 ·Il Farmaco ·Fabrizio Manetti, Stefano Forli, Laura Maccari, Federico Corelli, Maurizio Botta	25
18	α₁-Adrenoceptor Antagonists. 6. Structural Optimization of Pyridazinone−Arylpiperazines. Study of the Influence on Affinity and Selectivity of Cyclic Substituents at the Pyridazinone Ring and Alkoxy Groups at the Arylpiperazine Moiety 2003 ·Journal of Medicinal Chemistry ·Laura Betti, Federico Corelli, (unknown), Gino Giannaccini, Laura Maccari, Fabrizio Manetti, Giovannella Strappaghetti, Maurizio Botta	28
19	Synthesis and biological activity of new 1,4-benzodioxan-arylpiperazine derivatives. Further validation of a pharmacophore model for α1-adrenoceptor antagonists 2002 ·Bioorganic & Medicinal Chemistry ·Roberta Barbaro, Laura Betti, Maurizio Botta, Federico Corelli, Gino Giannaccini, Laura Maccari, Fabrizio Manetti, Giovannella Strappaghetti, Stefano Corsano	35
20	α₁-Adrenoceptor Antagonists. 4. Pharmacophore-Based Design, Synthesis, and Biological Evaluation of New Imidazo-, Benzimidazo-, and Indoloarylpiperazine Derivatives 2002 ·Journal of Medicinal Chemistry ·Laura Betti, Maurizio Botta, Federico Corelli, (unknown), Gino Giannaccini, Laura Maccari, Fabrizio Manetti, Giovannella Strappaghetti, Andrea Tafi, Stefano Corsano	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact